Endometrin
Payments companies reported to CMS as associated with Endometrin. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Endometrin, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Endometrin
These are the largest totals companies reported as associated with Endometrin. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Eve Feinberg | Chicago, IL | Reproductive Endocrinology | $1,812.00 |
| Brian Kaplan | Richmond, VA | Surgical Oncology | $265.94 |
| Valerie Ratts | Saint Louis, MO | Reproductive Endocrinology | $234.08 |
| Mitra Sharifi | Saint Louis, MO | Obstetrics & Gynecology | $234.08 |
| Anna Geiger | Saint Louis, MO | Women'S Health (Nurse Practitioner) | $234.08 |
| Dan Lebovic | Saint Louis, MO | Reproductive Endocrinology | $234.08 |
| Courtney Murphy | Saint Louis, MO | Obstetrics & Gynecology | $234.08 |
| Emily Spurlin | Homewood, AL | Obstetrics & Gynecology | $234.08 |
| Allison Rodgers | Glenview, IL | Obstetrics & Gynecology | $148.24 |
| Megan Sax | Hinsdale, IL | Obstetrics & Gynecology | $123.58 |
Prescribed Endometrin?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.